Logo image of ADN.CA

ACADIAN TIMBER CORP (ADN.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:ADN - CA0042721005 - Common Stock

15.5 CAD
+0.2 (+1.31%)
Last: 12/4/2025, 7:00:00 PM
Fundamental Rating

4

ADN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 12 industry peers in the Paper & Forest Products industry. ADN scores excellent on profitability, but there are concerns on its financial health. ADN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ADN was profitable.
In the past year ADN had a positive cash flow from operations.
In the past 5 years ADN has always been profitable.
ADN had a positive operating cash flow in each of the past 5 years.
ADN.CA Yearly Net Income VS EBIT VS OCF VS FCFADN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

ADN has a Return On Assets of 2.36%. This is amongst the best in the industry. ADN outperforms 83.33% of its industry peers.
Looking at the Return On Equity, with a value of 4.19%, ADN belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
ADN has a Return On Invested Capital of 1.63%. This is in the better half of the industry: ADN outperforms 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADN is in line with the industry average of 4.04%.
Industry RankSector Rank
ROA 2.36%
ROE 4.19%
ROIC 1.63%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ADN.CA Yearly ROA, ROE, ROICADN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ADN has a better Profit Margin (16.03%) than 100.00% of its industry peers.
ADN's Profit Margin has improved in the last couple of years.
ADN has a Operating Margin of 15.01%. This is amongst the best in the industry. ADN outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of ADN has declined.
ADN has a Gross Margin of 30.11%. This is amongst the best in the industry. ADN outperforms 100.00% of its industry peers.
ADN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.01%
PM (TTM) 16.03%
GM 30.11%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
ADN.CA Yearly Profit, Operating, Gross MarginsADN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

ADN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ADN has been increased compared to 1 year ago.
Compared to 5 years ago, ADN has more shares outstanding
ADN has a worse debt/assets ratio than last year.
ADN.CA Yearly Shares OutstandingADN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADN.CA Yearly Total Debt VS Total AssetsADN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 1.12, we must say that ADN is in the distress zone and has some risk of bankruptcy.
ADN's Altman-Z score of 1.12 is in line compared to the rest of the industry. ADN outperforms 41.67% of its industry peers.
The Debt to FCF ratio of ADN is 32.89, which is on the high side as it means it would take ADN, 32.89 years of fcf income to pay off all of its debts.
ADN's Debt to FCF ratio of 32.89 is in line compared to the rest of the industry. ADN outperforms 58.33% of its industry peers.
ADN has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ADN (0.33) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 32.89
Altman-Z 1.12
ROIC/WACC0.26
WACC6.19%
ADN.CA Yearly LT Debt VS Equity VS FCFADN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ADN has a Current Ratio of 0.96. This is a bad value and indicates that ADN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.96, ADN is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
A Quick Ratio of 0.88 indicates that ADN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.88, ADN is in line with its industry, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.88
ADN.CA Yearly Current Assets VS Current LiabilitesADN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

The earnings per share for ADN have decreased strongly by -48.15% in the last year.
ADN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.80% yearly.
Looking at the last year, ADN shows a very negative growth in Revenue. The Revenue has decreased by -28.86% in the last year.
ADN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.05% yearly.
EPS 1Y (TTM)-48.15%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%23.08%
Revenue 1Y (TTM)-28.86%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-11.33%

3.2 Future

ADN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.83% yearly.
The Revenue is expected to decrease by -3.68% on average over the next years.
EPS Next Y-52.71%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
EPS Next 5Y-4.83%
Revenue Next Year-28.61%
Revenue Next 2Y-2.74%
Revenue Next 3Y-3.68%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ADN.CA Yearly Revenue VS EstimatesADN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
ADN.CA Yearly EPS VS EstimatesADN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.45 indicates a rather expensive valuation of ADN.
Compared to the rest of the industry, the Price/Earnings ratio of ADN indicates a rather cheap valuation: ADN is cheaper than 83.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.46, ADN is valued a bit cheaper.
With a Price/Forward Earnings ratio of 20.74, ADN is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ADN indicates a somewhat cheap valuation: ADN is cheaper than 66.67% of the companies listed in the same industry.
ADN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.10.
Industry RankSector Rank
PE 18.45
Fwd PE 20.74
ADN.CA Price Earnings VS Forward Price EarningsADN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ADN.
ADN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 84.2
EV/EBITDA 27.31
ADN.CA Per share dataADN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The excellent profitability rating of ADN may justify a higher PE ratio.
A cheap valuation may be justified as ADN's earnings are expected to decrease with -10.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%

5

5. Dividend

5.1 Amount

ADN has a Yearly Dividend Yield of 7.45%, which is a nice return.
ADN's Dividend Yield is rather good when compared to the industry average which is at 6.14. ADN pays more dividend than 91.67% of the companies in the same industry.
ADN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 7.45%

5.2 History

The dividend of ADN decreases each year by -10.56%.
ADN has been paying a dividend for at least 10 years, so it has a reliable track record.
ADN has decreased its dividend recently.
Dividend Growth(5Y)-10.56%
Div Incr Years1
Div Non Decr Years1
ADN.CA Yearly Dividends per shareADN.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

ADN pays out 73.33% of its income as dividend. This is not a sustainable payout ratio.
ADN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP73.33%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
ADN.CA Yearly Income VS Free CF VS DividendADN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M
ADN.CA Dividend Payout.ADN.CA Dividend Payout, showing the Payout Ratio.ADN.CA Dividend Payout.PayoutRetained Earnings

ACADIAN TIMBER CORP

TSX:ADN (12/4/2025, 7:00:00 PM)

15.5

+0.2 (+1.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-10 2026-02-10
Inst Owners9.24%
Inst Owner ChangeN/A
Ins Owners0.65%
Ins Owner ChangeN/A
Market Cap283.50M
Revenue(TTM)85.21M
Net Income(TTM)14.13M
Analysts76.67
Price Target18.11 (16.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.45%
Yearly Dividend0.66
Dividend Growth(5Y)-10.56%
DP73.33%
Div Incr Years1
Div Non Decr Years1
Ex-Date12-31 2025-12-31 (0.29)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.32%
Min EPS beat(2)-40.59%
Max EPS beat(2)29.95%
EPS beat(4)2
Avg EPS beat(4)36.33%
Min EPS beat(4)-40.59%
Max EPS beat(4)164.03%
EPS beat(8)5
Avg EPS beat(8)101.8%
EPS beat(12)9
Avg EPS beat(12)176.18%
EPS beat(16)11
Avg EPS beat(16)130.41%
Revenue beat(2)1
Avg Revenue beat(2)-9.79%
Min Revenue beat(2)-31.34%
Max Revenue beat(2)11.76%
Revenue beat(4)1
Avg Revenue beat(4)-7.73%
Min Revenue beat(4)-31.34%
Max Revenue beat(4)11.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.37%
Revenue beat(12)4
Avg Revenue beat(12)-1.15%
Revenue beat(16)6
Avg Revenue beat(16)-0.65%
PT rev (1m)-8.97%
PT rev (3m)-8.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-37.57%
EPS NY rev (3m)-37.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-14.33%
Revenue NY rev (3m)-14.33%
Valuation
Industry RankSector Rank
PE 18.45
Fwd PE 20.74
P/S 3.22
P/FCF 84.2
P/OCF 40.56
P/B 0.84
P/tB 0.86
EV/EBITDA 27.31
EPS(TTM)0.84
EY5.42%
EPS(NY)0.75
Fwd EY4.82%
FCF(TTM)0.18
FCFY1.19%
OCF(TTM)0.38
OCFY2.47%
SpS4.82
BVpS18.41
TBVpS18.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.65
Profitability
Industry RankSector Rank
ROA 2.36%
ROE 4.19%
ROCE 2.27%
ROIC 1.63%
ROICexc 1.64%
ROICexgc 1.65%
OM 15.01%
PM (TTM) 16.03%
GM 30.11%
FCFM 3.82%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ROICexc(3y)2.73%
ROICexc(5y)2.88%
ROICexgc(3y)2.76%
ROICexgc(5y)2.92%
ROCE(3y)3.75%
ROCE(5y)3.95%
ROICexgc growth 3Y0.45%
ROICexgc growth 5Y-5.14%
ROICexc growth 3Y0.47%
ROICexc growth 5Y-5.06%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 32.89
Debt/EBITDA 7.67
Cap/Depr 328.17%
Cap/Sales 4.11%
Interest Coverage 3.75
Cash Conversion 48.76%
Profit Quality 23.84%
Current Ratio 0.96
Quick Ratio 0.88
Altman-Z 1.12
F-Score3
WACC6.19%
ROIC/WACC0.26
Cap/Depr(3y)780.67%
Cap/Depr(5y)518.79%
Cap/Sales(3y)3.37%
Cap/Sales(5y)2.17%
Profit Quality(3y)61.15%
Profit Quality(5y)72.04%
High Growth Momentum
Growth
EPS 1Y (TTM)-48.15%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%23.08%
EPS Next Y-52.71%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
EPS Next 5Y-4.83%
Revenue 1Y (TTM)-28.86%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-11.33%
Revenue Next Year-28.61%
Revenue Next 2Y-2.74%
Revenue Next 3Y-3.68%
Revenue Next 5YN/A
EBIT growth 1Y-48.28%
EBIT growth 3Y2.77%
EBIT growth 5Y1.28%
EBIT Next Year-10.76%
EBIT Next 3Y3.92%
EBIT Next 5YN/A
FCF growth 1Y-70.57%
FCF growth 3Y13.98%
FCF growth 5YN/A
OCF growth 1Y-41.26%
OCF growth 3Y28.01%
OCF growth 5YN/A

ACADIAN TIMBER CORP / ADN.CA FAQ

What is the ChartMill fundamental rating of ACADIAN TIMBER CORP (ADN.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ADN.CA.


What is the valuation status for ADN stock?

ChartMill assigns a valuation rating of 4 / 10 to ACADIAN TIMBER CORP (ADN.CA). This can be considered as Fairly Valued.


How profitable is ACADIAN TIMBER CORP (ADN.CA) stock?

ACADIAN TIMBER CORP (ADN.CA) has a profitability rating of 8 / 10.


How financially healthy is ACADIAN TIMBER CORP?

The financial health rating of ACADIAN TIMBER CORP (ADN.CA) is 2 / 10.


Can you provide the dividend sustainability for ADN stock?

The dividend rating of ACADIAN TIMBER CORP (ADN.CA) is 5 / 10 and the dividend payout ratio is 73.33%.